UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents

Leukemia, 2013-06, Vol.27 (6), p.1283-1290

2013

Volltextzugriff (PDF)

Donor-derived CD4+/CCR7+ T-cell partial selective depletion does not alter acquired anti-infective immunity

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.611-615

2014

Volltextzugriff (PDF)

High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM

Annals of hematology, 2013-05, Vol.92 (5), p.621-631

2013

Volltextzugriff (PDF)

HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.49-50

2019

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study

Journal of geriatric oncology, 2015-09, Vol.6 (5), p.346-352

2015

Volltextzugriff (PDF)

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia

Leukemia, 2006-03, Vol.20 (3), p.400-403

2006

Volltextzugriff (PDF)

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

Leukemia, 2003-11, Vol.17 (11), p.2168-2177

2003

Volltextzugriff (PDF)

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Leukemia, 2014-12, Vol.28 (12), p.2367-2375

2014

Volltextzugriff (PDF)

Erratum to: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM

Annals of hematology, 2013-05, Vol.92 (5), p.633-633

2013

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients

Bone marrow transplantation (Basingstoke), 2002-07, Vol.30 (2), p.95-102

2002

Volltextzugriff (PDF)

O-010 Prognostic factors of response to azacitidine (AZA) in low-risk MDS resistant to erythroid stimulating agents (ESA). The GFM Azaepo 08 study

Leukemia research, 2013-05, Vol.37, p.S13-S13

2013

Volltextzugriff (PDF)

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1302-1308

1997

Volltextzugriff (PDF)

The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease

Pathologie biologie (Paris), 2014-06, Vol.62 (3), p.123-128

2014

Volltextzugriff (PDF)

Impact de la composition du greffon sur le devenir des patients après une allogreffe de cellules souches hématopoïétiques : corrélation entre proportion des lymphocytes T CD4+ du greffon exprimant le CCR7 et la survenue d’une GVH aiguë

Pathologie biologie (Paris), 2014-06, Vol.62 (3), p.123-128

2014

Volltextzugriff (PDF)

219 Long-term outcome of anemic non del 5q lower-risk MDS refractory to or relapsing after erythropoiesis stimulating agents (ESAs)

Leukemia research, 2011, Vol.35, p.S86-S86

2011

Volltextzugriff (PDF)

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

Leukemia, 2021-06, Vol.35 (6), p.1745-1750

2021

Volltextzugriff (PDF)

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

Blood, 2003-07, Vol.102 (2), p.470-476

2003

Volltextzugriff (PDF)

Pyoderma gangrenosum induit par l’azacitidine dans un contexte de syndrome myélodysplasique

Annales de dermatologie et de vénéréologie, 2018-12, Vol.145 (12), p.S223-S223

2018

Volltextzugriff (PDF)

Donor-derived [CD4.sup.+]/[CCR7.sup.+] T-cell partial selective depletion does not alter acquired anti-infective immunity

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.611

2014

Volltextzugriff (PDF)

Donor-derived CD4 super(+)/CCR7 super(+) T-cell partial selective depletion does not alter acquired anti-infective immunity

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.611-615

2014

Volltextzugriff (PDF)

Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer

Bone marrow transplantation (Basingstoke), 2000-03, Vol.25 (6), p.681-682

2000

Volltextzugriff (PDF)

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

Blood, 2004-01, Vol.103 (2), p.435-441

2004

Volltextzugriff (PDF)

A randomized phase II trial of azacitidine +/- epoetin- in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents

Haematologica (Roma), 2016-08, Vol.101 (8), p.918-925

2016

Volltextzugriff (PDF)

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Haematologica (Roma), 2010-06, Vol.95 (6), p.892-899

2010

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(41)

Sprache

Englisch
(34)
Französisch
(7)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents

Donor-derived CD4+/CCR7+ T-cell partial selective depletion does not alter acquired anti-infective immunity

High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM

HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY

Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Erratum to: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients

O-010 Prognostic factors of response to azacitidine (AZA) in low-risk MDS resistant to erythroid stimulating agents (ESA). The GFM Azaepo 08 study

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results

The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease

Impact de la composition du greffon sur le devenir des patients après une allogreffe de cellules souches hématopoïétiques : corrélation entre proportion des lymphocytes T CD4+ du greffon exprimant le CCR7 et la survenue d’une GVH aiguë

219 Long-term outcome of anemic non del 5q lower-risk MDS refractory to or relapsing after erythropoiesis stimulating agents (ESAs)

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

Pyoderma gangrenosum induit par l’azacitidine dans un contexte de syndrome myélodysplasique

Donor-derived [CD4.sup.+]/[CCR7.sup.+] T-cell partial selective depletion does not alter acquired anti-infective immunity

Donor-derived CD4 super(+)/CCR7 super(+) T-cell partial selective depletion does not alter acquired anti-infective immunity

Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

A randomized phase II trial of azacitidine +/- epoetin- in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Suchergebnisse filtern